Snake bites in Nigeria: A study of the prevalence and treatment in Benin City

Similar documents
66 ISSN East Cent. Afr. J. surg

Venomous Snake Bite Injuries at Kitui District Hospital

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

. Analgesics and antipyretics (tabkt mefanemic acid

By the end of this lecture students will be able to understand Importance, epidemiology, pathogenesis of snake bite Clinical manifestations

Clinical Profile of Envenomation in Children With Reference To Snake Bite

Envenomation by the hump nosed viper (hypnale hypnale) in children: a pilot study

Clinical Profile of Snake Bite in Children in Rural India. Vinayak Y. Kshirsagar, MD; Minhajuddin Ahmed, MD; Sylvia M.

Snake bites in north east Sri Lanka

WHO/SEARO GUIDELINES FOR THE CLINICAL MANAGEMENT OF SNAKE BITES IN THE SOUTHEAST ASIAN REGION

Snake Bite Kit Caution!

Materials and Methods: Anti-snake venom activities of Asparagus racernosus

Venomous Snakebite in Mountainous Terrain: Prevention and Management

Clinical Features, Management and Outcome of Snake Bite in Children in Manipal Teaching Hospital

Epidemiological profile of snake bite at tertiary care hospital, East India

An Epidemiological study on Snakebite in Karwar

5 Dangerous Venom Types Thailand Snakes. Thailand Snake Venom Types:

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

DOWNLOAD OR READ : SNAKE BITE PDF EBOOK EPUB MOBI

3 RD INTERNATIONAL SUMMIT ON TOXICOLOGY & APPLIED PHARMACOLOGY OCTOBER 20-22, 2014 CHICAGO, USA

VENOMOUS SNAKE BITES IN LAO PDR: A RETROSPECTIVE STUDY OF 21 SNAKEBITE VICTIMS IN A PROVINCIAL HOSPITAL

Characteristics of snake envenomation in eastern India, a study of epidemiology, complications and interventions

IJBCP International Journal of Basic & Clinical Pharmacology

UT HEALTH EMERGENCY MEDICINE & TRAUMA GUIDELINES

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

CLINICAL PROFILE OF SNAKE BITE CASES IN MARATHWADA, INDIA

Management of Snake Bite in Saudi Arabia

Common Viper Bites in the Czech Republic Epidemiological and Clinical Aspects during 15 Year Period ( )

SNAKEBITE MANAGEMENT: Experiences From Gulu Regional Hospital Ugandz

Clinical profile and outcome of snake bite in children

Delayed reporting to health care facilities: a significant determinant of fatalities in cases of snake bites

Clinical Profile and Outcome of Envenomous Snake-Bite At Tertiary Care Centre In Nellore- A Retrospective Study

SNABIRC-KENYA A GUIDE TO MANAGING SNAKEBITES

Impact of First Aid Training in Management of Snake Bite Victims in Madi Valley

International Journal of Pharma and Bio Sciences V1(1)2010

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

The Most Venomous Dangerous Deadly Poisonous Snakes?

SNAKE BITE; FREQUENCY OF VARIOUS CLINICAL PRESENTATIONS OF ADMITTED PATIENTS AND AVERAGE TIME TO REACH HOSPITAL

Snake-Bite Present Scenario In Bangladesh. Dr A K M Humayon Kabir Associate professor Dept. of Medicine Dhaka Medical College

Routine antibiotic therapy in the management of the local inflammatory swelling in venomous snakebites: results of a placebo-controlled study

Author - Dr. Josie Traub-Dargatz

Snake bite envenoming in Bangladesh and the challenge of biodiversity

Submission for Reclassification

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

ESTIMATES OF DISEASE BURDEN DUE TO LAND-SNAKE BITE IN SRI LANKAN HOSPITALS

Outcomes of Snakebite Envenomation in Children

Methods. Objective. Results

DO NOT ATTEMPT TO CAPTURE OR HANDLE SNAKES

SNAKE ENVENOMATION. RYAN DE VOE DVM, MSpVM, DACZM, DABVP-Avian. Modified by Michael R.Loomis, DVM, MA, DACZM North Carolina Zoological Park

Bites by non-native venomous snakes in the United States

Malayan Pit Viper Venomous Very Dangerous

Poultry Science Journal ISSN: (Print), (Online)

GARP ACTIVITIES IN KENYA. Sam Kariuki and Cara Winters

WildlifeCampus Advanced Snakes & Reptiles 1. Vipers and Adders

ORIGINAL ARTICLE A STUDY OF CLINICAL PROFILE OF SNAKE BITE. Annamalai University, Annamalainagar

Antimicrobial resistance at different levels of health-care services in Nepal

Cobras By Guy Belleranti

SNAKE AWARENESS, FIRST AID FOR SNAKEBITE CORPORATE SOUTH AFRICA & VENOMOUS SNAKE HANDLING COURSES ////////////////////

Medically important snakes in Sri Lanka

Of the Cape Peninsula

Insect Bite Avoidance

Super Toxic Thailand Sea Snakes

TOXOIDING OF SNAKE VENOM AND EVALUATION OF IMMUNOGENICITY OF THE TOXOIDS

Snake Bite Toolkit (08)

Epidemiology of Snakebites from A General Hospital in Singapore: A 5-year Retrospective Review ( )

Considerations in antimicrobial prescribing Perspective: drug resistance

Spiders and Snakes Martin Belson, MD

Influences on tetanus immunization in

6/20/2018. A Public Benefit Corporation. A First-in-Class Snakebite Antidote. Discovery to Accelerated Development

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Fish Envenomation. Tony Alleman, MD MPH FACOEM UHM

Who should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3

Spencer Greene, MD, MS, FACEP, FACMT

الكلب عضة = bite Dog Saturday, 09 October :56 - Last Updated Wednesday, 09 February :07

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

American Association of Feline Practitioners American Animal Hospital Association

The Miracle Cat: The Treatment of a Cat that was bitten by a Tiger Snake

Standard Operating Procedure for Rabies. November Key facts

SUMMARY OF PRODUCT CHARACTERISTICS

SPREADSHEET MODELS FOR FOCUSING RESEARCH ON HIGH YIELD PREVENTION AND CONTROL STRATEGIES

Clinical Aspects of Green Pit Viper Bites in Bangladesh: A Study on 40 Patients

Guidelines on prescribing antibiotics. For physicians and others in Denmark

The Anti Snake Venom Crisis in Africa: A Suggested Manufacturers Product Guide

Early Onset Neonatal Sepsis (EONS) A Gregory ST6 registrar at RHH

Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children

The above question was submitted to four authorities and the following replies were received:

SNAKE AWARENESS, FIRST AID CORPORATE AFRICA FOR SNAKEBITE & VENOMOUS SNAKE HANDLING COURSES ///////////////

ISMP Canada HYDROmorphone Knowledge Assessment Survey

Source: Portland State University Population Research Center (

The Bushmaster Silent Fate of the American Tropics The natural history of the largest, most dangerous viper in the world

VENOM WEEK 2005 (Formerly "Snakebites in the New Millenium: A State-of-the-Art-Symposium" Friday, October 21, 2005: Field Trip, Introductions and

Bacterial infections in the urinary tract

Antimicrobial Use and Antimicrobial Resistance in Relation to the Canadian Pork Sector Presented by Jorge Correa Pork Committee Banff May 2013

Introduction to Medically Important Spiders

IMPACT OF SNAKE BITES AND DETERMINANTS OF FATAL OUTCOMES IN SOUTHEASTERN NEPAL

Neutralization of Micrurus distans distans venom by antivenin (Micrurus fulvius)

Antibiotics utilization ratio in a Neonatal Intensive Care Unit

All about snakes. What are snakes? Are snakes just lizards without legs? If you want to know more

CLINICAL MASTITIS PERCEPTIONS OF KANSAS DAIRY PRODUCERS. J.R. Roberson 1

Transcription:

Tropical Journal of Pharmaceutical Research, June 2002; 1 (1): 39-44 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria. All rights reserved. Available online at http://www.tjpr.freehosting.net Research Article Snake bites in Nigeria: A study of the prevalence and treatment in Benin City Eric K. I. Omogbai, Zuleikha A. M. Nworgu, Michael A. Imhafidon, Anwakang A. Ikpeme, David O. Ojo and Charles N. Nwako Department of Pharmacology & Toxicology, Faculty of Pharmacy, University of Benin, Benin City, Nigeria Abstract Purpose: Although snake bites occur frequently in Benin City, the prevalence has not been documented. This study was therefore done to determine the prevalence, morbidity, mortality, and the orthodox treatment of victims. Methods: The study was retrospective and data on victims of snake bite covering a period of twenty years were obtained from the records as contained in the individual patients case files available at the University of Benin Teaching Hospital and Central Hospital, Benin City. Results: Males were twice more often bitten than females, and teenagers and youths in their early twenties constituted the peak age range of victims. Most victims (59.5%) were bitten in the bush or farm. The limbs were the commonest sites of bite with the feet (73.5%) and arms (20.9%) more frequently bitten; both the upper and lower right limbs were also more frequently bitten than the corresponding left limbs. All patients who showed symptoms of envenomation (68.3%) received polyvalent antivenom, 67.4% received antibiotics while over 90% of patients received antitetanus prophylaxis. Some of the patients (61.5 %) were treated with analgesics, while 17.2% and 82.3% received diazepam and intravenous fluids, respectively. Although there was a high degree of morbidity as shown by the long stay of many patients in the hospital (mean duration of stay by patients in hospital is 5.7±5.1 days; range <1-23 days), mortality was not recorded. Conclusion: It is concluded that there is a high prevalence of snake bites with high morbidity especially among the very active youthful segment of the Benin City population. Key words: Snakebite, prevalence, treatment, Benin City. To whom correspondence should be addressed. E-mail: omog@uniben.edu 39

Introduction Snakebite is a common occurrence in Nigeria as indeed in many parts of the tropics. The incidence and type of snake seem to vary according to the geographical zone, the occupational practices of the population and the season. It has been observed that the incidence of snake bite is seasonal and there is a peak during the rainy season a time when frogs and toads emerging from their hibernation are preyed on by snakes that thereby come in frequent contact with humans, and when farmers engage in intense farming activities that also bring them frequently in contact with snakes in the bush 1, 2. Venomous snakes are found throughout most of the world and are believed to cause in excess of 3 million bites per year with more than 150,000 deaths 3. The venomous snakes in Africa are known to belong to four main families the colubridae, elapidae, viparide and hydrophidae 4 - but in Nigeria, the most common poisonous snakes are the elapids and viperids 5. These include the Naja melanoleuca (black cobra) and N. nigricolis (spitting cobra), and the viperid Echis carinatus (carpet viper) and Bitis arietans (puff adder). Although most of the offending snakes reported in a study carried out in Zaria (a City located in northern part of Nigeria) were not identified, 69.6% of those identified belonged to the viperidae family while 30.4% were cobras (colubridae) 1. Snake bites, are however, not confined to bush encounters as a significant numbers of victims are known to be bitten in their abodes; some while sleeping indoors. It is known that snake bites occur frequently in Benin City, which is located in the tropical rain forest belt of South Western Nigeria, but the incidence has not been documented despite the fact that the condition is a recognized medical emergency. This retrospective study has therefore been done to determine the 40 prevalence and the drug treatment of victims. Patients and methodology The study was done retrospectively in University of Benin Teaching Hospital, (UBTH) and Central Hospital in Benin City (CH) over a twenty-year period (1980-1999). Both hospitals are tertiary health care centres; UBTH is a 550-bed Federal governmentowned hospital while CH is a 500-bed Stateowed referral health care centre. All patients treated for snake bikes in UBTH (226 patients) and CH (209 patients) from 1980 to 1999 were included in the study. Basic data such as the hospital number, cause for admission as well as the dates of admission and discharge for each case were obtained from the general records kept in the hospitals and the information was used to trace the relevant case files in the records archives from which the necessary data were collected. In extracting data from the case notes, special attention was paid to the age and sex of each victim, the part of the body bitten, the treatment given and the length of stay in the hospital, if admitted. The collection of data was done in two phases: the data spanning 1980 to 1990 were compiled in 1994 while those of the 1991 to 1999 period were collected in 2000. The data collected were then pooled and analysed in this report. The means and standard deviations were calculated for ages and durations of stay in hospital and where necessary, the Student t- test was used to compare the means. At 95% confidence interval, p-values less than or equal to 0.05 were considered to be significant. Results A total of 435 cases comprising 292 males and 143 females were recorded in the twentyyear period. Figure 1 shows the age and sex distribution of the victims. The overall mean age of victims was 26.2±18.2 years while the mean ages of male and female victims were

25 Number of victims by sex as % of male or female total 20 15 10 5 0 1.0-5.0 6.0-10.0 11.0-15 16-20 21-25 26-30 31-35 36-40 41-45 46-50 51-55 56-60 61-65 66-70 71-75 76-80 81-85 Age range (years) Figure 1: Percentage of victims of snake bites per age group based on sex. Age range:1-82 years (males), 3-65 years (females); mean age ± sd: 26.2±18.2, 25.5±15.7 (males), 27.5±14.8 (females) 25.5±15.5 and 27.5±14.8 years, respectively. The youngest male and female victims were one and five years old respectively while the oldest male and female were 82 and 65 years respectively. The age of greatest vulnerability appears to be the teenage years and early twenties (Figure 1). There was no significant difference in the average ages of the male and female victims. The records showed that bites were frequently inflicted on the limbs; the right foot (41.8%), left foot (31.7%), right arm (14%) and left arm (6.9%). Bites on other parts of the body and spraying of venom into the eyes were also recorded (Table 1). Majority of patients, 259 (59.7%), were bitten in the bush, farm or on the road, and a significant number, 164 (37.7%), were bitten while outdoors around their homes while 12 (2.8%) were bitten inside their houses (Table 1). Table 1: Common sites and places of bite Site Number of % victims Right lower limb 182 41.8 Left lower limb 138 31.7 Right upper limb 61 14.0 Left upper limb 30 6.9 Head 3 0.7 Trunk 11 2.5 Spittle (into eyes) 3 0.7 Site not specified 7 1.6 Total 435 100 Place In the bush 259 59.5 Within the 164 37.8 compound Inside the house 12 2.7 Total 435 100 Table 2 indicates the duration of stay of patients in the hospital. Of the total of 435 41

Table 2: Length of stay of patients in hospital Duration (days) Number of % of total patients < 1 70 16.1 2-5 168 38.6 6-10 99 22.8 11-15 48 11.0 16-20 11 2.5 21-25 1 0.2 Unspecified 38 8.7 Total 435 100 Duration of stay (days, mean±sd) = 5.7±5.1 patients recorded in both hospitals, 397 were accounted for with regard to the duration of stay in the hospital. For the remaining 38 all of whom were recorded at CH, there was no indication as to their duration of stay. The records showed that 70 patients (16.1%) were treated and discharged the same day. The longest staying patient was in the hospital for 23 days. The mean duration of stay by victims in hospital was 5.7± 5.1 days. The drugs commonly used for the treatment of victims are shown in Table 3. Two hundred and ninety-seven victims (68.3%) received antivenom (polyvalent) treatment while 67.4% received antibiotics. The most commonly used Table 3: Treatment profile of the victims Number of % usage patients Antivenom 297 68.3 (polyvalent) Antibiotics 293 67.4 Intravenous fluids 358 82.3 Antitetanus serum 359 87.5 Antitetanus toxoid 395 90.8 Andrenaline 126 29.0 Corticosteroids 100 23.0 Antihistamines 101 23.2 Analgesics 267 61.4 Chymotrypsin 125 28.7 (chymoral ) Diazepam 75 17.2 Local anaesthetics 2 0.5 Vitamins (K ; C) 6 (1;5) 1.4 (0.2;1.2) antibiotic agent was ampiclox while others that featured included ampicillin, metronidazole, gentamycin, benzylpenicillin, procaine penicillin and cotrimoxazole. Approximately equal numbers of patients received antihistamines (23.2%) mainly promethazine and chlorpheniramine and corticosteroids (23%). Twenty-nine percent were treated with adrenaline, 82.5% received antitetanus toxoid, 61.5% received analgesics while 17.2% were given diazepam. Some of the patients (28%) received chymotripsin and 82.3% of the victims received intravenous fluids. One patient received Vitamin K for spontaneous bleeding. The site of bite was commonly topically disinfected with hydrogen peroxide, gentian violet or chlorinated lime and boric acid solution. Discussion It is known that snake bites in many parts of the tropics (especially the developing countries) are treated either by traditional healers at home or by orthodox practitioners in hospitals such that many cases are not reported to the hospital unless the traditional healer has failed to effect a cure and the victim survives to be taken to a hospital 6. Hospital records may therefore not fully account for the prevalence of snake bites in the community. In Benin City however, the two major health health care centres have been surveyed in this study to obtain an approximation of the prevalence of snakebites in the city. In this study, the ratio of male to female victims is approximately 2:1 as against the general population ratio of approximately 1:1 7. This suggests that males are twice more likely to be bitten than females. This may be due to the fact that males are more adventurous and are therefore liable to have more frequent encounters with snakes. Some victims were bitten even indoors, indicating that people of all ages are potential victims despite the fact that the records show that the youngest and oldest victims were males. The intensity of 42

exposure and bite frequency for both sexes appear to be highest in teenage years and in the early twenties the most physically active years with the least amount of caution. Most bites were inflicted on limbs and there is evidence of a dextral predominance. The fact that most individuals favour the right hand and right foot and are therefore more likely to reach out or probe first with the right may account for this. Many patients appear to have been treated and discharged on the first or second day. This would be the case of bites with little or no envenomation in which there may be few or no symptoms. Even in cases of envenomation with delayed reaction, the severity would have been known by the second day to enable a decision to be taken whether to discharge or keep the patient. The treatment profiles show that over 90% of patients were given tetanus antitoxin and/or tetanus toxoid. Tetanus prophylaxis is essential in snakebite because of the nature of the bites (puncture wounds) and the fact that snakes carry pathogenic organisms including Clostridium tetani as part of their normal oral microflora 5. This predisposes victims of bites even of non-venomous snakes to the danger of developing tetanus subsequently if not treated. This, along with the risk of infections by other pathogenic bacteria, justifies the use of the antibiotics identified in this study. While the penicillins are safe and useful for tetanus prophylaxis 6, other antibiotics as recorded in this survey are also useful for preventing or combating bacterial complication. There was no recorded case of tetracycline use in this study although our unpublished data of general antibiotic prescription patterns in the two hospitals show a 3.1% use of tetracyclines. Tetracyclines are usually avoided in snakebite because of the risk of aggravating the acute renal failure which may occur with severe snake bite poisoning 8. All patients who apparently showed signs of envenomation (68.3%) received antivenom (polyvalent in all cases) since, from the records, many of the snakes were usually not killed or identified but even when identified, specific antivenom is usually not readily available. When antivenom is used in the treatment of snakebite, hypersensitivity reactions are common and these usually warrant the use of adrenaline and corticosteroids and sometimes antihistamines. Early severe local tissue swelling, inflammation and haemorrhagic manifestations accompany viper bites and similar reactions have been reported for spitting cobra bites. 2,3 It was observed in this survey that chymotrypsin has been used frequently as an adjunct in the treatment of cases with tissues oedema and inflammation. Supportive fluid treatment may be advisable when shock is severe while the administration of a sedative like diazepam may be used to control pain and anxiety the latter of which could be pronounced even when there is no envenomation. Fear tends to complicate the treatment of snakebite as people have been known to suffer from shock after being bitten by non-poisonous snakes 4. Diazepam is however not recommended in the treatment of victims of elapid snakebites with venoms that cause muscle paralysis and eventual respiratory failure in order not to exacerbate the paralysis. A surprising observation in this study, despite the high morbidity indicated by cases of prolonged confinement in the hospital of many patients, is the apparent absence of mortality. Although the fate of 8.7% of the victims was not recorded, no mortality was indicated. In a study of snake envenomation in children covering a period of ten years, LoVecchio and DeBus 9 recorded no mortality among sixty-six victims of rattlesnake bites in a metropolitan area of Arizona in the United States and Chen et al recorded no mortality among 130 victims of poisonous snake bites in northern Taiwan during a 3-year period 10. However, the global mortality rate from snake bites appears to be about 5% of the victims. 3 Ogala and Obaro 1 reported a 3.9% mortality rate among children bitten by snakes in Zaria, 43

Idoko and Ibekwe 11 recorded a mortality rate of 5.7% in 175 cases recorded in a two-year period in Makurdi, Nigeria while other researchers have also reported low mortality rates among victims of snake bites in different 12, 13, 14 parts of the tropics. It has been suggested by these and other researchers that snake bites in the tropics are mainly escape bites in which only small amounts of venom are injected into the victims as against business bites in which large volumes of 14, 15 venom are injected. It is also likely that the patients were usually brought early to the hospitals and had adequate and prompt care these being tertiary/tertiary and the bestequipped public hospitals in Edo State. Conclusion In conclusion, snakebite cases presented to the hospitals in Benin City were more common among males. Victims are more likely to be teenagers and youths in their twenties. While bites were more common outdoors people were also vulnerable indoors. The hospitals seem to have established adequate and effective treatment regimens for snake bite victims as no mortality was recorded during the period surveyed. Acknowledgements The authors are grateful to the Chief Medical Directors of the UBTH and CH for providing access to their records for the purpose of collecting data for this study. References 1. Ogala WN, Obaro SK. Venomous Snake Bites in Children in the Tropics: the Zaria Experience. Nig. Med. Pract., 1999; 26: 11-13. 2. Warrel DA. Snake bite in sub-saharan Africa. Afr. Hlth., 1999; 21: 5-9. 3. White J. Bites and stings from venomous animals: a global overview. Ther. Drug Monit., 2000; 22: 65-68. 4. Warrel DA. Animal and disease. In: Parry EHO ( e d ). Principles of Medicine in Africa, ed 2, Oxford University Press,. 1984, p 110. 5. Akubue PI. Poisons in our Environment and Drug Overdose. A guide for Health Professionals and the Lay Public. Enugu, Snaaps Press Ltd, 1997, pp 77-82. 6. Reid HA, Lam KJ. Snake bite. A survey of fishing village in North-West Malaya. Br. Med. J., 1957; 2: 1266-1272. 7. National Population Commission. Nigeria at a glance (Nigeria 1991 Population Census), 1995 p. 2. 8. Reid HA. Bites and Stings. In: Scott RB (ed). Price s Textbook of the Practice of Medicine, 12 th ed, 12, Oxford University Press, 1978; pp 239-246. 9. LoVecchio F, DeBus DM. Snakebite envenomation in children: a 10-year retrospective review. Wilderness Environ. Med., 2001; 12: 184-189. 10. Chen JC, Liaw SJ, Bullard MJ, Chiu TF. Treatment of poisonous snakes in northern Taiwan. J. Formos. Med. Assoc., 2000; 99:135-139. 11. Idoko A, Ikwueke K, Snakebite in the tropics: experience in Makurdi, Nigeria. Trop. Geogr. Med., 1984; 36: 175-178. 12. Onuaguluchi GO. Clinical observations on snake bites in Wukari, Nigeria. Trans. R. Soc. Trop. Med. Hyg., 1960; 54:265-269. 13. Swaroops, GB. Snake bite mortality in the world. Bull. Wld. Hlth. Org., 1954; 10:35-76. 14. Reid HA. Snake bite clinical features (part 1) and treatment (part 2). Trop. Doct., 1972; 2:155-163. 15. Reid HA. Diagnosis, prognosis and treatment of sea snake bite. Lancet, 1961; 2: 399-402. 44